PepsiCo (PEP)

Consumo básico / Bebidas y alimentos convenientes

The other defensive consumer giant: beverages (PBNA/IB) + convenient foods (Frito-Lay), with an operating margin ~15% more modest than a pure concentrate model but a considerably cheaper multiple than its closest peer. At ~$127 (P/E 16×) with volume under pressure (−2% organic) but GAAP earnings depressed by FY2025 non-recurring charges, base case 5-year value ~$177 (+7%/year price, +12% with a 4.7% dividend): Undervalued — a quality business with an identifiable source of discount, not just a low multiple that looks cheap.

Moat Compounder estimates the intrinsic value of PepsiCo (PEP) at $177 per share on a five-year horizon. With the stock at $126.68 at 2026-10-12 close, the expected total return is 11.6% per year: undervalued. The analysis draws on 10-K FY2025 and 10-Q Q1 2026. Analysis dated 2026-10-08.

Price
$126.68
at 2026-10-12 close
Intrinsic value (5y, base)
$177
Total annual return (5y)
11.6%
6.9% price · 4.7% div
Status (nominal)
Undervalued
Margin of safety
+26%

The essentials

  • Two mass-consumption engines: Frito-Lay (snacks, global leader) + PBNA/IB (beverages, #2 behind Coca-Cola), with a dividend that grew in each of the last three fiscal years (yield 4.7%) and an operating margin ~15%, more capital-intensive than that of a pure concentrate business.
  • FY2025 was hit by non-recurring charges of ~$2,910M: $1,946M of impairment and other charges (which include, without breakdown, the impairment of the Rockstar brand tied to the Celsius swap, split across PBNA $1,523M, IB Franchise $73M, EMEA $270M and Be & Cheery in Asia Pacific Foods $80M) plus $964M of restructuring, which pushed GAAP operating profit down 11% — but the TTM has already left them behind and net income attributable recovered to $10,896M. Organic volume fell 2% (offset by +4% price/mix) while the productivity plan and the North America recovery remain in progress.
  • Trades at 16× net income — unlike a low multiple that only appears cheap, here there is an identifiable source of discount (the GAAP noise from charges plus execution uncertainty around the recovery).
Source 10-K FY2025 Dec-27-2025 ·10-Q Q1 2026 Mar-21-2026 ·10-Q Q2 2026 Jun-13-2026 ·10-Q Q3 2026 Sep 5, 2026 ·8-K 3Q 2026 results (press release) Oct 8, 2026 ·DEF 14A 2026 (proxy) Mar 27, 2026
Health: Solid
Price $127 at 2026-10-12 closeMarket Cap $173.2 bnEnterprise Value $214.4 bnNet debt $41.2 bnP/E (today) 15.9x

Intrinsic value — two valuation methods

Fairly valued
Price market
$127
DCF value today
$220
+73.6% vs price
Multiples value today
$172
+35.8% vs price

Total return at 5 years: 11.7%/year = 6.9% appreciation + 4.7% dividend. The target price ($177) is ex-dividend; the $34 in dividends collected over 5 years are added separately.

By both methods, the value today (DCF $220 · Multiples $172) exceeds the market price ($127).

Pillars of the analysis

The verdict — today vs 5 years

Today — fairly valued: at $127 trades ~26.4% below its value discounted to today (~$172); the discount is positive but does not reach the margin of safety we require (≥38%).

At 5 years — Infravalorado: the target price ($177) plus dividends yield above the required average return (10%) — the business compounds.

The bridge: the return at 5 years exceeds the risk-free rate (4.5%) — but the discount does not reach the required margin of safety (≥38%). To require a 15% annual return, it would need to be bought at ~$111.

Thesis

The business

PepsiCo is a high-quality but not exceptional mass-consumption business: two engines (snacks + beverages) with leading brands and a distribution network that a new entrant cannot replicate quickly, but a more capital-intensive model than a pure concentrate business (operating margin ~15% vs ~29% for its closest beverage comparable). Volume is under structural pressure (GLP-1, sugar taxes, private label) and the North America recovery remains underway, accompanied by active portfolio curation (poppi, Siete, the Rockstar-for-Celsius exchange) that renews the moat rather than only defending it.

The valuation

Valued on P/E over net income attributable, which gives the equity value directly. At ~$127 PepsiCo trades at 16× TTM net income.

The base case projects a +3.5% starting growth rate — guided organic growth (~3%) plus a residual contribution from acquisitions: the TTM's +6.4% is not extrapolated (it includes net acquisitions and currency translation that the 3Q release separates from organic growth), nor is a volume recovery that organic growth (~+2%, with volume at −2%) does not yet show credited in advance — decelerating to +3.0% by year 5, with net margin expanding modestly (from ~11.1% to ~11.6%) as FY2025's non-recurring charges do not repeat and the productivity plan delivers. The exit multiple (18× terminal, 19× at 3 years) re-rates only slightly from today's level — not an aggressive expansion, but the normalization of a multiple currently compressed by GAAP noise. That yields ~$177/share at five years → a price CAGR of ~+7%/year; with the dividend (4.7% yield, growing ~5%/year), the total return is around ~+12%.

The margin of safety

It trades at a real discount to value, though short of the required margin of safety. The reverse-DCF is the cross-check: comparing the growth today's price demands against the ~5.4%/year of net income the base case projects helps gauge whether the market is paying for more than the business is likely to deliver. The verdict is Undervalued: a solidly quality, not exceptional, business bought with an identifiable source of discount — not just a low multiple that appears to be one.

What to watch

The gauge is twofold. First, volume: if organic volume (−2% in 2025) does not stabilize — due to GLP-1, AI purchasing agents, sugar taxes or private-label pressure — pricing power is not enough to sustain reported growth. The second-quarter earnings release (8-K, July 9, 2026) affirmed fiscal 2026 guidance of organic growth between 2% and 4%, consistent with the projected path, which offers some near-term reassurance without clearing the underlying doubt. Second, execution of the North America priorities plan announced in 2025, together with the 2019 productivity plan (in effect through 2030, with ~$2,540M in charges still to be incurred): if the recovery is delayed, the multiple — already compressed — could keep compressing instead of normalizing. The quality of the business (leading brands + distribution, renewed with poppi/Siete/Celsius) is not in doubt; the speed of the margin and volume recovery is.

Educational / informational. Does not constitute investment advice.

Other companies of the same type